332 VALIDATION OF DIGITALIZED HEALTH STATUS QUESTIONNAIRES FREQUENTLY USED IN THE MONITORING OF OSTEOARTHRITIS: A CROSS SECTIONAL STUDY  by Gudbergsen, H.R.
Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256 S147
While the WOMAC pain and physical function scores indicated a mild to
moderate level of pain and disability over the past 48 hours, prospective
data collection (Participant Diary) detected higher levels of knee pain
when the highest score reported of the 7 day period was utilized (highest
7-day knee pain). Further, the prospective 7-day Participant Diary also
demonstrated almost half of the study participants (44%) with a mean
global assessment of their knees as only ‘fair’ or ‘poor’.
A simple Participant Diary requiring daily recording of knee pain speciﬁed
as ‘at its worst’ on a 11 point rating scale over one week may provide an
inexpensive, robust and responsive outcome measure in long term clinical
trials compared to retrospective reporting of pain (past 48 hours) but
without descriptive speciﬁcity.
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VALIDATION OF DIGITALIZED HEALTH STATUS QUESTIONNAIRES
FREQUENTLY USED IN THE MONITORING OF OSTEOARTHRITIS: A CROSS
SECTIONAL STUDY
H.R. Gudbergsen Sr.
The Parker Inst., Frederiksberg, Capital Region, Denmark
Purpose: To validate digitalized Health Status Questionnaires (HSQs) used
for sampling Patient Reported Outcomes for knee osteoarthritis (KOA) pa-
tients, employing newly developed freeware on touch screens. Furthermore
to examine the effect of patient characteristics on differences between
HSQ-versions.
Methods: Touch screen answers were compared to answers on paper
versions of the most commonly used HSQs in the clinical management of
KOA, and participants were recruited from an ongoing in-house KOA trial
(the CAROT-study; ClinicalTrials.Gov Identiﬁer: NCT00655941). 20 female
participants, mean age 67 (SD 7), completed KOOS, SF-36, ADL Taxonomy,
Physical Activity Scale, VAS pain, function and patient global and Pain
Detect, and the trial proﬁle ensured testing of only one HSQ at the time
in a repeated randomized cross-over design. The two HSQ versions (paper
and touch screen) were completed with a 5 min. interval and between
each HSQ patients had a 5 min. break. Mean values for each version,
mean differences (95% CI), pooled means, medians, median differences,
Minimal Important Differences and Spearman correlation coeﬃcients were
calculated for all HSQs including relevant subscales.
Results: Correlations between touch screen and paper version of SF-36
were 0.92 for the physical component summary scale and 0.81 for the
mental component summary scale. Similar correlations for KOOS ranged
from 0.88 to 0.98, and the other instruments were tested with comparable
results. When analysing mean and median differences we found no consis-
tent pattern in differences between the two measures, nor were there any
systematic patterns in the differences between HSQ-versions. No signiﬁcant
inﬂuence was observed of age, former computer experience or level of
education on differences between the two HSQ-versions. The participants
did not need further help or explanations when ﬁlling out questionnaires
on screen and found the process easier than ﬁlling in paper versions of the
questionnaire. 16 of 20 overall preferred the touch screen version.
Correlation between paper- and touch-screen versions
Paper version Spearmans Correlation Touch Screen
Coeﬃcient Version
KOOS 0.97 KOOS
VAS pain 0.89 VAS pain
VAS function 0.87 VAS function
VAS patient global 0.78 VAS patient global
SF-36Physical Component Summary Scale 0.92 SF-36Physical Component Summary Scale
SF-36Mental Component Summary Scale 0.81 SF-36Mental Component Summary Scale
Physical Activity Scale 0.84 Physical Activity Scale
Pain Detect1 0.97 Pain Detect1
Pain Detect2 0.96 Pain Detect2
Pain Detect3 0.95 Pain Detect3
Pain Detect4 0.86 Pain Detect4
Pain Detect5 0.88 Pain Detect5
Pain Detect6 0.91 Pain Detect6
ADL Taxonomia 0.95 ADL Taxonomia
Conclusions: The digitalized HSQs on touch screen gave statistically com-
parable results to answers given on a paper version of the same HSQs. Use
of electronic questionnaires gives a safer and more precise data collection
due to direct registration of answers, and implementation as well as use of
this freeware is feasible for patients
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SHORT FORM-36 (SF-36) AND EUROQOL-5 DIMENSION (EQ-5D) RESULTS
FROM RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDIES OF TAPENTADOL
PROLONGED RELEASE (PR) IN PATIENTS WITH MODERATE TO SEVERE
CHRONIC NOCICEPTIVE AND NEUROPATHIC PAIN
R. Lange1, B. Lange1, A. Greene2, A. Okamoto2, M. Etropolski2,
J. Ashworth1
1Global Dev., Grünenthal GmbH, Aachen, Germany; 2Johnson & Johnson
Pharmaceutical Res. & Dev., L.L.C., Raritan, NJ
Purpose: To summarize SF-36 and EQ-5D health survey results from four
15-week, double-blind phase 3 studies of tapentadol PR in patients with
osteoarthritis (OA) pain (NCT00421928 [OA study 1] and NCT00486811
[OA study 2]), low back pain (NCT00449176), and pain related to diabetic
peripheral neuropathy (DPN; NCT00455520).
Methods: In the OA and low back pain studies, patients received placebo,
tapentadol PR (100-250 mg bid), or oxycodone HCl controlled release (CR;
20-50 mg bid) during a 3-week titration period and a 12-week maintenance
period. In the DPN study, patients received tapentadol PR (100-250 mg bid)
during a 3-week open-label titration period; patients with at least a 1-point
improvement in pain intensity (11-point numerical rating scale [NRS])
were randomized to receive placebo or their optimal dose of tapentadol
PR (determined in the titration period) during a 12-week double-blind
maintenance period. SF-36 and EQ-5D health survey questionnaires were
used to assess health status. The SF-36 consists of 8 dimensions (physical
functioning, role-physical, bodily pain, general health, vitality, social func-
tioning, role-emotional, and mental health) measured on a 0 to 100 NRS
(0 = being in poor health to 100 = being in good health) and summarized
as physical component and mental component summaries. The EQ-5D con-
sists of 5 dimensions (mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression), which are measured using 3 possible levels (“no
problems,” “some problems,” and “extreme problems”) and summarized
